Poster Session 1: Late Effects/Quality of Life/Psychosocial Issues

Track: Poster Abstracts
Wednesday, February 11, 2015: 6:45 PM-7:45 PM
Grand Hall CD (Manchester Grand Hyatt)

213
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Prathima Anandi, MD, National Heart, Lung, and Blood Institute, NIH; Natasha A Jain, MD, National Heart, Lung, and Blood Institute, NIH; Colin Wu, Phd, National Heart, Lung, and Blood Institute, NIH; Xin Tian, PhD, National Heart, Lung, and Blood Institute, NIH; Priyanka A Pophali, MD, National Heart, Lung, and Blood Institute, NIH; Eleftheria Koklanaris, RN, National Heart, Lung, and Blood Institute, NIH; Neil Dunavin, MD, National Heart, Lung, and Blood Institute, NIH; Sawa Ito, MD, National Heart, Lung, and Blood Institute, NIH; Robert Q Le, MD, Phd, National Heart, Lung, and Blood Institute, NIH; Bipin N. Savani, MD, Vanderbilt University Medical Center; A. John Barrett, MD, National Heart, Lung, and Blood Institute, NIH; Minoo Battiwalla, MD, MS, National Heart, Lung, and Blood Institute, NIH

214
Incidence and Risk Factors for Metabolic Syndrome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients- a Tertiary Care Center Experience
Surabhi Batra, MD, Ann & Robert H. Lurie Children's Hospital of Chicago; Karina Danner-Koptik, RN, MSN, APN-CPON, Ann and Robert H. Lurie Children's Hospital of Chicago; Morris Kletzel, MD, FAAP, MBA, Northwestern University Feinberg School of Medicine

215
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
Guang-Shing Cheng, MD, Fred Hutchinson Cancer Research Center; Iskra Pusic, MD, Washington University Medical Center; Madan H. Jagasia, MD, MBBS, MS, Vanderbilt University Medical Center; Linda J. Burns, MD, National Marrow Donor Program/Be The Match; Vincent T. Ho, MD, Dana-Farber Cancer Institute; Joseph Pidala, MD, PhD, H. Lee Moffitt Cancer Center and Research Institute; Jeanne Palmer, MD, Mayo Clinic Arizona; Laura Johnston, MD, Stanford University Medical Center; Sebastian Mayer, MD, Weill Cornell Medical Center; Xiaoyu Chai, MS, Fred Hutchinson Cancer Research Center; Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center; Kirsten M. Williams, MD, CNMC/National Cancer Institute, NIH

216
Life after Transplant: The Use of Group in Preparation for Transition Home
Alix Beaupierre, RN, BSN, OCN, H. Lee Moffitt Cancer Center; Lynda Cook Gannon, LCSW, Moffitt Cancer Center; Becky Dame, Moffitt Cancer Center; Ashur Dee Brown, H. Lee Moffitt Cancer Center; Jolene Rowe, H. Lee Moffitt Cancer Center

217
Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Moussab Damlaj, MD, Mayo Clinic; Gabriel Bartoo, PharmD, Mayo Clinic; Desire Gijima, MD, University of Iowa; Shahrukh Hashmi, MD, MPH, Mayo Clinic Rochester; Mark R. Litzow, MD, Mayo Clinic Rochester; William Hogan, MBBCh, Mayo Clinic; Mrinal Patnaik, MBBS, Mayo Clinic

218
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Ellen M Denzen, MS, National Marrow Donor Program /Be The Match; Elizabeth A Murphy, EdD, RN, National Marrow Donor Program /Be The Match; K. Scott Baker, MD, MS, Fred Hutchinson Cancer Research Center; Beatrice Abetti, LCSW, Leukemia & Lymphoma Society; Balkrishna Jahagirdar, MD, Regions Hospital; Naynesh R Kamani, MD, AABB; J. Douglas Rizzo, MD, MS, CIBMTR and Medical College of Wisconsin; Wael Saber, MD, MS, Medical College of Wisconsin; Lizette Salazar, RDH, HCT Recipient; Barry A Schatz, Cardinal Bernardin Cancer Center; Karen L. Syrjala, PhD, Fred Hutchinson Cancer Research Center; John R. Wingard, MD, University of Florida; Navneet S. Majhail, MD, MS, Cleveland Clinic

219
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Areej El-Jawahri, MD, Massachusetts General Hospital; Lara Traeger, PhD, Massachusetts General Hospital; Kailyn Kuzmuk, Massachusetts General Hospital; Justin Eusebio, Massachusetts General Hospital; Harry Vandusen, Massachusetts General Hospital; Tanya Keenan, MD, Massachusetts General Hospital; Jennifer Shin, Massachusetts General Hospital; Emily Gallagher, Massachusetts General Hospital; Joseph Greer, PhD, Massachusetts General Hospital; William Pirl, MD, Massachusetts General Hospital; Vicki Jackson, MD, Massachusetts General Hospital; Karen K. Ballen, MD, Massachusetts General Hospital; Thomas R. Spitzer, MD, Massachusetts General Hospital; Timothy Graubert, MD, Massachusetts General Hospital; Steven L. McAfee, MD, Massachusetts General Hospital; Bimalangshu R Dey, MD, PhD, Massachusetts General Hospital; Yi-Bin Chen, MD, Massachusetts General Hospital; Jennifer Temel, MD, Massachusetts General Hospital

220
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
John P Galvin, MD, Northwestern University Feinberg School of Medicine; Katherine Ehrlich, PhD, Northwestern University; Swati Baveja, Northwestern Univesrity; Thomas Scheide, Northwestern University; Catherine Valukas, Northwestern University; Frank Penedo, PhD, Northwestern University; Greg Miller, PhD, Northwestern University; Jayesh Mehta, MD, Northwestern University Feinberg School of Medicine

222
A Single Center Survey of Distress Amongst Bone Marrow Transplant Recipients
Mark Fesler, MD, Saint Louis University; Crystal Elaina Weaver, CRC, MT-BC, Saint Louis University; Kimberly McCormick, RMA, Saint Louis University; Andrew Dwiggins, MT-BC, Saint Louis University; Sagun D Goyal, MD, MSc, Saint Louis University

223
Rhythmic Entrainment: A Music Therapy Intervention to Elicit Relaxation and Decrease Anxiety for the Bone Marrow Transplant Recipient
Crystal Elaina Weaver, CRC, MT-BC, Saint Louis University; Andrew Dwiggins, MT-BC, Saint Louis University; Kimberly McCormick, RMA, Saint Louis University; Mark Fesler, MD, Saint Louis University; Sagun D Goyal, MD, MSc, Saint Louis University

225
Anicteric Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation in Children
Rajinder Bajwa, MBBS, MRCP, MD, Nationwide Children's; Jeffrey Naples, DO, Nationwide Children's Hospital/The Ohio State University; Micah Skeens, RN MS PNP, Nationwide Childrens

226
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Rachel Phelan, MD, MPH, University of Minnesota; Elizabeth Mann, MD, University of Minnesota; Char Napurski, MPH, University of Minnesota; Todd E Defor, MS, University of Minnesota; Anna Petryk, MD, University of Minnesota; Weston P Miller, MD, University of Minnesota; John E. Wagner, MD, University of Minnesota; Michael R. Verneris, MD, University of Minnesota Medical Center, Fairview; Angela R. Smith, MD, MS, University of Minnesota Medical Center, Fairview

227
Bone Health Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Daniel Ernst, MD, Pontifical Catholic University; Pablo Florenzano, MD, Pontifical Catholic University; Claudia Campusano, MD, Pontifical Catholic University; Veronica Jara, RN, Pontifical Catholic University; Pablo Bertin, MD, Pontifical Catholic University; Pablo A Ramirez, MD, Pontifical Catholic University

228
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Guillermo J Ruiz-Delgado, MD, Laboratorios Clinicos de Puebla, Clinica Ruiz; Samantha L Galindo-Becerra, MD, Clinica Ruiz de Puebla; Nancy Labastida-Mercado, MD, Clinica Ruiz de Puebla; Angelica Gonzalez-Cortes, MD, Universidad Popular Autonoma del Estado de Puebla; Nora A Martagon-Herrera, MD, Clinica Ruiz de Puebla; Monica P Gonzalez-Ramirez, MD, Clinica Ruiz de Puebla; Javier Garces-Eisele, MD, Laboratorios Clinicos de Puebla, Clinica Ruiz; Alejandro Ruiz-Arguelles, MD, Laboratorios Clinicos de Puebla, Clinica Ruiz; Guillermo J Ruiz-Arguelles, MD, Clinica Ruiz

229
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Nancy Labastida-Mercado, MD, Clinica Ruiz de Puebla; Samantha L Galindo-Becerra, MD, Clinica Ruiz de Puebla; Monica P Gonzalez-Ramirez, MD, Clinica Ruiz de Puebla; Karla Miravete-Lagunes, MD, Universidad de las Americas Puebla; Andres Gomez-de-Leon, MD, Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran; Sergio Ponce-de-Leon, MD, Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran; Andrea P Tenorio-Rojo, MD, Clinica Ruiz de Puebla; Nora A Martagon-Herrera, MD, Clinica Ruiz de Puebla; Jesus A Hernandez-Reyes, MD, Clinica Ruiz de Puebla; Arturo Garcia-Villasenor, MD, Universidad de las Americas Puebla; Esteban Burguette-Hernandez, MD, Universidad de las Americas Puebla; Guillermo J Ruiz Delgado, MD, Clinica Ruiz de Puebla; David Gomez-Almaguer, MD, University Hospital of Monterrey; Guillermo J Ruiz-Arguelles, MD, Clinica Ruiz

230
Increased Incidence of Fatigue in Pediatric Hematopoetic STEM CELL Transplant Recipients
Jessica R Sarkees, RN, CPNP-AC, Children's Medical Center Dallas; Victor Aquino, MD, University of Texas Southwestern Medical Center; Julie Germann, PhD, Children's Medical Center Dallas; Andrew Young Koh, MD, University of Texas Southwestern Medical Center; Tara Pavlock, RN, CPNP-AC, Children's Medical Center Dallas

231
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Erica S Savig, Stanford University School of Medicine; Jacqueline H Gurevitch, Stanford University School of Medicine; Jordan E Jackson, Stanford University School of Medicine; Amber Malinowski, Stanford University; Larry J Leifer, PhD, Stanford University; Rajni Agarwal-Hashmi, MD, Stanford University School of Medicine; Barbara M Sourkes, PhD, Stanford University School of Medicine; Harvey J Cohen, MD, PhD, Stanford University School of Medicine; Wendy G Ju, PhD, Stanford University

232
Metabolic Syndrome Occurs within the First Year after Hematopoietic Cell Transplant
Kerry K McMillen, MS, RD, CSO, Seattle Cancer Care Alliance; Erin M Schmidt, RD, CSO, Seattle Cancer Care Alliance; Barry E. Storer, PhD, Fred Hutchinson Cancer Research Center; Merav Bar, MD, Fred Hutchinson Cancer Research Center

233
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Hannah E. Spencer, MSc, University of Virginia School of Medicine; Tamila L Kindwall-Keller, DO, MS, University of Virginia School of Medicine; Amer Beitinjaneh, MD, MPH, MS, University of Virginia School of Medicine; Laura P. Smith, MD, Reproductive Medicine and Surgery Center of Virignia; Jessica K. Malpass, PhD, RN, University of Virginia School of Nursing; Ryan P. Smith, MD, University of Virginia School of Medicine; Tanya D. Thomas, RN, OCN, University of Virginia Health System; Leonid Volodin, MD, University of Virginia School of Medicine; Michael G. Douvas, MD, University of Virginia School of Medicine; Linda R Duska, MD, University of Virginia

234
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Hannah E. Spencer, MSc, University of Virginia School of Medicine; Geoffrey Barkley, LCSW, PhD, University of Virginia; Laura P. Smith, MD, Reproductive Medicine and Surgery Center of Virignia; Gana Elizabeth Locker, University of Virginia Health System; Diana O. Rexrode, RN, University of Virginia; Amer Beitinjaneh, MD, MPH, MS, University of Virginia School of Medicine; Leonid Volodin, MD, University of Virginia School of Medicine; Lisa Huntsinger, RN, MSN, CCRN, University of Virginia Health System; Tamila L Kindwall-Keller, DO, MS, University of Virginia School of Medicine

235
Long-Term Stable Mixed Chimerism in Patients Undergoing HSCT for Non-Malignant Disorders
Arwen Stikvoort, Karolinska University Hospital; Jonas Mattsson, MD PhD, Karolinska University Hospital; Mikael Sundin, MD PhD, Karolinska University Hospital; Michael Uhlin, PhD, Karolinska University Hospital

236
Women's Health and Hormonal Treatment Options for Therapeutic Amenorrhea and Contraception during the Peri-Transplant Period
Katherine Chang, MD, Northwestern; Melissa Merideth, MD, National Human Genome Institute; Pamela Stratton, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development

237
Early Diagnosis of Labial Fusion Enables Medical Treatment in an Office Setting
Claire Scrivani, BS, NHLBI, NIH; Melissa Merideth, MD, National Human Genome Institute; Tajana Klepac Pulanic, MD, Program in Reproductive and Adult Endocrinology; Steven Z. Pavletic, MD, National Cancer Institute, National Institutes of Health; Richard W. Childs, MD, National Heart, Lung, and Blood Institute; Matthew Hsieh, MD, National Institutes of Health; Pamela Stratton, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development

See more of: Poster Abstracts